1. Home
  2. NVCR vs SHO Comparison

NVCR vs SHO Comparison

Compare NVCR & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • SHO
  • Stock Information
  • Founded
  • NVCR 2000
  • SHO 1995
  • Country
  • NVCR Switzerland
  • SHO United States
  • Employees
  • NVCR N/A
  • SHO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • SHO Hotels/Resorts
  • Sector
  • NVCR Health Care
  • SHO Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • SHO Nasdaq
  • Market Cap
  • NVCR 1.9B
  • SHO 1.7B
  • IPO Year
  • NVCR 2015
  • SHO 1995
  • Fundamental
  • Price
  • NVCR $17.77
  • SHO $8.99
  • Analyst Decision
  • NVCR Buy
  • SHO Hold
  • Analyst Count
  • NVCR 7
  • SHO 8
  • Target Price
  • NVCR $32.43
  • SHO $9.56
  • AVG Volume (30 Days)
  • NVCR 1.5M
  • SHO 2.8M
  • Earning Date
  • NVCR 07-24-2025
  • SHO 08-06-2025
  • Dividend Yield
  • NVCR N/A
  • SHO 4.00%
  • EPS Growth
  • NVCR N/A
  • SHO N/A
  • EPS
  • NVCR N/A
  • SHO 0.10
  • Revenue
  • NVCR $621,711,000.00
  • SHO $922,708,000.00
  • Revenue This Year
  • NVCR $5.56
  • SHO $7.67
  • Revenue Next Year
  • NVCR $9.19
  • SHO $3.45
  • P/E Ratio
  • NVCR N/A
  • SHO $91.64
  • Revenue Growth
  • NVCR 18.27
  • SHO N/A
  • 52 Week Low
  • NVCR $14.17
  • SHO $7.45
  • 52 Week High
  • NVCR $34.13
  • SHO $12.41
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 52.02
  • SHO 55.68
  • Support Level
  • NVCR $16.81
  • SHO $8.70
  • Resistance Level
  • NVCR $18.70
  • SHO $9.08
  • Average True Range (ATR)
  • NVCR 0.73
  • SHO 0.23
  • MACD
  • NVCR 0.04
  • SHO 0.02
  • Stochastic Oscillator
  • NVCR 62.75
  • SHO 84.17

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

Share on Social Networks: